Identification of A1286C Methylenetetrahydrofolate Reductase Gene Polymorphism in Orbital Region Basal Cell Carcinoma Patients
Article Sidebar
Abstract
Background: The development of basal cell carcinoma (BCC) shows variations among individuals. The risk factor for development of BCC related to environtmental factor especially exposure to ultraviolet radiation and individual factor. The one of internal risk factor contribute to basal cell carcinoma developmental is genetic instability include defects in folic acid synthesis or DNA synthesis. The critical enzim that participate in the process is regulated by Methylenetetrahydrofolate Reductase (MTHFR) gene.
Method: This study was descriptive observational with case study involved 10 orbital region basal cell carcinoma. The diagnosis was based on histopathologic examination of the tumor. Genotype frequencies of A1286C polymorphism were studied by Polymerase Chain Reaction (PCR), amplification and restriction fragment length polymorphism analyses using MboII enzyme.
Result: In the present study, from 10 subjects we found male was 7 people (70%) and female was 3 people (30%). Majority of subjects have history of having a job in the sunlight. The most commont of the BCC is nodular (80%). There is one subject with recurrent case. Analysis result of A1286C MTHFR gene show wild type in all cases.
Conclusion: There’s no A1286C substitution methylenetetrahydrofolate reductase gene were identified. The whole subjects are wild type.
Keywords: basal cell carcinoma, orbital region, folic acid, polymorphism, A1286C MTHFR gene, polymerase chain reaction (PCR), wild type
Full text article
References
Lacour JP. Carcinogenesis of basal cell carcinomas:genetics and molecular mechansisms. Br J Dermatol2002;146(Suppl 61):17–19.
Duong HQ, Copeland R. Basal cell carcinoma, eyelid. Emedicine, 2001.
Lear W, Dahlke E, Murray CA. Basal cell carcinoma: review of epidemiology, pathogenesis, and associated risk factors. J Cutan Med Surg. 2007;11(1):19-30.
Tilli CML, Steensel MAM, et al. Molecular aetiology and pathogenesis of basal cell carcinoma. British Journal of Dermatology 2005;152:1108-24.
Lacour JP. Carcinogenesis of basal cell carcinomas: geneticsand molecular mechanisms. Br J Dermatol 2002;146(Suppl.61):17-9.
Kim Y I. cancer Epidemiology Biomarker. Prev 2004; 13:511-9.
Stern LL, Mason JB, Selhub J, Choi SW. Genomic DNA hypomethylation,a characteristic of most cancers, is present inperipheral leukocytes of individuals who are homozygousfor the C677T polymorphism in the methylenetetrahydrofolatereductase gene. Cancer Epidemiol Biomarkers Prev 2000;9:849-53.
Lesiak A et al, an enhanced risk of basal cell carcinoma is associated with particular polymorphism in the VDR and MTHFR genes, experimental. Dermatology 2011;20:200-4.
Festa F, Kumar R, Sanyal S, et al. Basal cell carcinoma andvariants in genes coding for immune response, DNA repair,folate and iron metabolism. Mutat Res 2005;574:105-11.
Iannocene MR dket al, Patterns and timing of sunlight exposure and riskof basal cell and squamous cell carcinomas of theskin – a case–control study, BMC Cancer 2012;12:1-11.
Branda, RF et al, Skin Colorand nutrient photolysis: an evolutionary hypothesis. Science;201:625-6.
Friso S, Choi SW, Gene-Nutrient Interactions and DNA methylation. American Society for Nutritional Science 2002;132:2382-2387.
Kim YI. Folate and Carcinogenesis.Evidence, mechanisms and implications. Journal Nutritional Biochemical, 1999;10; 66-88.
Weisberg et al. A second genetic polymorphisms in MTHFR associated with decreased enzyme activity. Mol genet Metabolims 1998;64:169-172.
Festa F, Kumar R, Sanyal S, et al. Basal cell carcinoma andvariants in genes coding for immune response, DNA repair,folate and iron metabolism. Mutat Res 2005;574:105-11.
Marks R.an overview of skin cancers: incidence and causation.1995;75:607-12.
Naskiewicz et al, Association of methylenetetrahydrofolate reductase gene polymorphism with basal cell carcinoma development, Post Dermatol Alergol, vol 28, 1, hal 1-5, 2007.
Milstone EB, Helwig EB, Basal cell carcinoma in children. Arch Dermatology 1973;108:523-7.